Skip to main content
OpenTrials

Clinical trial condition

Spasms, Infantile

Explore clinical trials studying Spasms, Infantile. Study availability and eligibility vary by location and protocol.

28 public trials 6 recruiting studies
Refine in advanced search Browse all conditions

Spasms, Infantile trial results

Completed

A Randomized, Controlled Trial of Ganaxolone in Patients With Infantile Spasms

NCT00441896

Conditions
Brain Diseases, Central Nervous System Diseases, Epilepsy, +5 more
Locations
  • Children's Hospital of Los Angeles Los Angeles, California, United States
  • Mattel Children's Hospital at UCLA Los Angeles, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Miami Children's Hospital, The Brain Institute Miami, Florida, United States
View all 15 locations
View Trial Details
Completed

Phase 3 Trial of Cannabidiol (CBD; GWP42003-P) for Infantile Spasms: Open-label Extension Phase (GWPCARE7)

NCT02954887

Conditions
Brain Diseases, Central Nervous System Diseases, Epilepsy, +5 more
Locations
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Wake Forest Baptist Medical Center Winston-Salem, North Carolina, United States
  • Nationwide Children's Hospital Columbus, Ohio, United States
  • Le Bonheur Children's Hospital Memphis, Tennessee, United States
View Trial Details
Completed

Trial of Cannabidiol (CBD; GWP42003-P) for Infantile Spasms (GWPCARE7)

NCT02953548

Conditions
Brain Diseases, Central Nervous System Diseases, Epilepsy, +5 more
Locations
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Wake Forest Baptist Medical Center Winston-Salem, North Carolina, United States
  • Nationwide Children's Hospital Columbus, Ohio, United States
  • Le Bonheur Children's Hospital Memphis, Tennessee, United States
View Trial Details
Completed

A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-935 (OV935) as an Adjunctive Therapy in Pediatric Participants With Developmental and/or Epileptic Encephalopathies

NCT03650452

Conditions
Brain Diseases, Brain Ischemia, CDKL5 deficiency disorder, +35 more
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Colorado Children's Hospital Aurora, Colorado, United States
  • Nicklaus Children's Hospital Miami, Florida, United States
View all 44 locations
View Trial Details
Completed

Epilepsy Phenome/Genome Project

NCT00552045

Conditions
Brain Diseases, Central Nervous System Diseases, Congenital Abnormalities, +20 more
Locations
  • University of Alabama at Birmingham, Epilepsy Center, 1719 6th Ave S, CIRC, Ste 312 Birmingham, Alabama, United States
  • Mayo Clinic College of Medicine Arizona Phoenix, Arizona, United States
  • University of California, San Francisco, 400 Parnassus, Room 847 San Francisco, California, United States
  • The Children's Hospital Denver, Colorado, United States
View all 25 locations
View Trial Details
Completed

Acceptability Study of a New Paediatric Form of Vigabatrin in Infants and Children With Infantile Spasms or Pharmacoresistant Partial Epilepsy

NCT02220114

Conditions
Brain Diseases, Central Nervous System Diseases, Epilepsy, +5 more
Locations
  • Service de neurologie pédiatrique - CHU Amiens, France
  • Service de neurologie pédiatrique - CHU Angers, France
  • Service de neuropédiatrie - CHU Pellegrin Enfants Bordeaux, France
  • Service de neurologie infantile - Hôpital Salengro Lille, France
View Trial Details

Related conditions